Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Jun 1, 2021 SC 13G/A
8-K May 17, 2021 8-K
SC 13G May 10, 2021 SC 13G
10-Q May 7, 2021 10-Q
8-K May 6, 2021 8-K
DEF 14A Apr 30, 2021 DEF 14A
8-K Apr 26, 2021 8-K
424B3 Apr 23, 2021 424B3
424B5 Apr 23, 2021 424B5
PRE 14A Apr 14, 2021 PRE 14A
S-8 Mar 26, 2021 S-8
10-K Mar 26, 2021 10-K
8-K Mar 25, 2021 8-K
SC 13G/A Mar 15, 2021 SC 13G/A
SC 13G Mar 10, 2021 SEC SCHEDULE 13G
SC 13G Feb 19, 2021 SEC SCHEDULE 13G
SC 13G/A Feb 16, 2021 SC 13G/A
SC 13G/A Feb 16, 2021 SCHEDULE 13G (AMENDMENT #1)
4 Feb 8, 2021 FORM 4 SUBMISSION
4 Feb 8, 2021 FORM 4 SUBMISSION
4 Feb 8, 2021 FORM 4 SUBMISSION
4 Feb 8, 2021 FORM 4 SUBMISSION
4 Feb 8, 2021 FORM 4 SUBMISSION
3 Jan 21, 2021 FORM 3 SUBMISSION
4 Jan 21, 2021 FORM 4 SUBMISSION
← Newer Page 15 of 33 · 819 filings Older →